Log In
Print
BCIQ
Print
Print this Print this
 

abaloparatide-SC (BA058-SC) (formerly BA058 Injection)

Also known as: formerly BIM44058

  Manage Alerts
Collapse Summary General Information
Company Ipsen Group
DescriptionSubcutaneous formulation of a peptide analog of parathyroid hormone-related protein (PTHrP)
Molecular Target Parathyroid hormone (PTH) receptor
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentPhase III
Standard IndicationOsteoporosis
Indication DetailsPrevent fractures in postmenopausal women with severe osteoporosis; Treat osteoporosis in postmenopausal women
Regulatory Designation

Partner

Radius Health Inc.; Teijin Pharma Ltd.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today